A number of factors, such as the rising burden of cardiovascular diseases (CVDs), neurological disorders, and cancer, increasing availability of technologically improved products, escalating healthcare spending, and soaring geriatric population, are expected to fuel the nuclear imaging equipment market at a CAGR of 4.8% during the forecast period (2017–2023). Nuclear imaging equipment is used to diagnose cancer, investigate blood circulation, and evaluate organ disorders through radiations emitted by radioisotopes used in such medical products.
Access Detailed Report Nuclear Imaging Equipment Market Competitive Analysis Report @ https://www.psmarketresearch.com/market-analysis/nuclear-imaging-equipment-market
The growing prevalence of cancer, CVDs, and neurological disorders will drive the demand for nuclear imaging equipment globally. The International Agency for Research on Cancer (IARC) states that 19,292,789 new cases of cancer were recorded in 2020. Further, the World Health Organization (WHO) reported that CVDs accounted for over 32% of all deaths across the world in 2019. The organization also states that 55 million people around the world are currently suffering from dementia, and 60–70% of these cases are Alzheimer's disease.
Additionally, the mounting aging population will also facilitate the nuclear imaging equipment market growth in the forecast years, as geriatric people are highly vulnerable to CVDs globally. As aging slows heart rate due to fat deposits and enhances the heart size, old people are highly vulnerable to heart attacks and strokes. As per the United Nations Department of Economic and Social Affairs (UNDESA), the global population of individuals aged 65 years or over will rise from 727 million in 2020 to more than 1.5 billion by 2050.
According to P&S Intelligence, the North American nuclear imaging equipment market generates the highest revenue, wherein the U.S. accounts for the largest share. The dominance of North America can be attributed to the high prevalence of CVDs and cancer and largescale availability of technologically advanced products in the region. For instance, the Canadian Cancer Society estimates that 2 in 5 Canadians are expected to develop cancer in their lifetime. Likewise, the Centers for Disease Control and Prevention (CDC) states that 1,708,921 people were diagnosed with cancer in 2018.
Therefore, the increasing burden of cancer, neurological diseases, and CVDs and expanding population base of old people are prominent growth drivers of the market.
This study covers
• Major factors driving the market and their impact during the short, medium, and long terms
• Market restraints and their impact during the short, medium, and long terms
• Recent trends and evolving opportunities for the market participants
• Historical and the present size of the market segments and understand their comparative future potential
• Potential of on-demand logistics services, so the market players make informed decisions on the sales of their offerings
• Competitive scenario of various market segments across key countries in several regions for uncovering market opportunities for the stakeholders
• Major players operating in the market and their service offerings